Tocilizumab for Giant Cell Arteritis-A New Giant Step in an Old Disease

JAMA Neurol. 2018 Feb 1;75(2):145-146. doi: 10.1001/jamaneurol.2017.3811.

Authors

Hiromichi Tamaki¹, Rula A Hajj-Ali²

Affiliations

¹ Division of Vasculitis, Immuno-Rheumatology Center, St Luke's International Hospital, St Luke's International University, Tokyo, Japan.
² Center for Vasculitis Care and Research, Cleveland Clinic Lerner College of Medicine, Orthopaedic and Rheumatologic Institute, Cleveland, Ohio.

PMID: 29255889
DOI: 10.1001/jamaneurol.2017.3811

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Giant Cell Arteritis / drug therapy*
Humans
Immunologic Factors / therapeutic use*
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Immunologic Factors
tocilizumab